Kuoyuan Cheng
- Co-authors
- Eytan RuppinSanju SinhaAlejandro A. SchäfferEyal SchiffKenneth AldapeNishanth Ulhas NairQing XiaXudong Feng
- Topics
- SARS-CoV-2 and COVID-19 Research (3 papers)CAR-T cell therapy research (3 papers)COVID-19 Clinical Research Studies (3 papers)
- Partner nations
- United StatesIsraelChina
In The Last Decade
Kuoyuan Cheng
15 papers receiving 263 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 146
- Infectious Diseases 66
- Epidemiology 25
- Oncology 24
- Physiology 22
Countries citing papers authored by Kuoyuan Cheng
This map shows the geographic impact of Kuoyuan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuoyuan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuoyuan Cheng more than expected).
Fields of papers citing papers by Kuoyuan Cheng
This network shows the impact of papers produced by Kuoyuan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuoyuan Cheng. The network helps show where Kuoyuan Cheng may publish in the future.
Co-authorship network of co-authors of Kuoyuan Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Kuoyuan Cheng. A scholar is included among the top collaborators of Kuoyuan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuoyuan Cheng. Kuoyuan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 5 | |
| 3 | 9 | |
| 4 | 29 | |
| 5 | 34 | |
| 6 | 3 | |
| 7 | 36 | |
| 8 | 1 | |
| 9 | 12 | |
| 10 | 0 | |
| 11 | 43 | |
| 12 | Large population study identifies drugs associated with reduced COVID-19 severity | 11 |
| 13 | 8 | |
| 14 | 41 | |
| 15 | 19 | |
| 16 | 8 |
About Kuoyuan Cheng
Kuoyuan Cheng is a scholar working on Geriatrics and Gerontology, Infectious Diseases and Oncology, having authored 16 papers that have together received 267 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), CAR-T cell therapy research (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (66 citations), Aging (6 citations) and Geriatrics and Gerontology (13 citations). Kuoyuan Cheng has collaborated with scholars based in United States, Israel and China. Frequent co-authors include Eytan Ruppin, Sanju Sinha, Alejandro A. Schäffer, Eyal Schiff, Kenneth Aldape, Nishanth Ulhas Nair, Qing Xia, Xudong Feng, Jiaqi Lü and Joo Sang Lee. Their work appears in journals such as Nature Communications, Cancer Research and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.